ArticleInternational journal of surgery (London, England)2026

Efficacy, safety, and biomarkers of neoadjuvant trastuzumab and pertuzumab combined with chemotherapy in Chinese patients with HER2-positive breast cancer: a multicenter retrospective cohort study.

Xiaowei Qi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.